Literature DB >> 28885729

Leptin induces matrix metalloproteinase 7 expression to promote ovarian cancer cell invasion by activating ERK and JNK pathways.

Ahmad Ghasemi1, Seyed Isaac Hashemy2, Mahmoud Aghaei1, Mojtaba Panjehpour1.   

Abstract

Leptin, an adipokine secreted by adipose tissue, induces cell invasion and metastasis. MMP7 is a member of the matrix metalloproteinase family that plays an important role in cell invasion. Here we evaluate the possible role and underlying mechanism of MMP7 in the leptin-mediated cell invasion in ovarian cancer cell lines. All experiments were carried out in cultured SKOV3, OVCAR3, and CaoV-3 ovarian cell lines. MMP7 expression was determined using the Western blot following treatment to various concentrations of leptin for defined time intervals. The activation of ERK, JNK, and P38 MAP kinases were determined using Western blotting. Wound healing and BD matrigel invasion assays were used to measure cell migration and invasion. The siRNA approach and pharmacological inhibitors of ERK and JNK pathway were used to confirm the receptor-dependent effect of leptin and a role for ERK and JNK pathway. Zymography assay was employed to determine MMP2 and MMP9 activation. Results show that leptin induces ERK1/2 and JNK1/2 activation and subsequently promotes MMP7 expression in SKOV3 (4.8 ± 0.14 fold of control, P < 0.01) and OVCAR3 (3.1 ± 0.19 fold of control, P < 0.01) ovarian cancer cell lines. These effects was reversed by knockdown of OB-Rb and/or pre-incubation with PD98059 (ERK1/2 inhibitor), SP600125 (JNK1/2 inhibitor). Gelatin zymography showed that MMP7 gene silencing attenuated leptin-induced MMP9 activation in SKOV3 cell line. Taken together, our results suggest new evidences for a modulatory effect of leptin in regulation of ovarian cancer cell invasion by stimulating MMP7 expression via ERK and JNK pathways.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell invasion; leptin; matrix metalloproteinase 7; ovarian cancer

Mesh:

Substances:

Year:  2017        PMID: 28885729     DOI: 10.1002/jcb.26396

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  17 in total

Review 1.  Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women.

Authors:  Eunice Nyasani; Iqbal Munir; Mia Perez; Kimberly Payne; Salma Khan
Journal:  Endocrine       Date:  2018-09-14       Impact factor: 3.633

2.  Estrogen-independent role of ERα in ovarian cancer progression induced by leptin/Ob-Rb axis.

Authors:  Ahmad Ghasemi; Jafar Saeidi; Mahnaz Mohtashami; Seyed Isaac Hashemy
Journal:  Mol Cell Biochem       Date:  2019-05-10       Impact factor: 3.396

Review 3.  The potential role of leptin in tumor invasion and metastasis.

Authors:  Amitabha Ray; Margot P Cleary
Journal:  Cytokine Growth Factor Rev       Date:  2017-11-11       Impact factor: 7.638

Review 4.  Gynaecological cancers and leptin: A focus on the endometrium and ovary.

Authors:  A Ray; J Fornsaglio; S Dogan; S Hedau; D Naik; A De
Journal:  Facts Views Vis Obgyn       Date:  2018-03

5.  PCNA and JNK1-Stat3 pathways respectively promotes and inhibits diabetes-associated centrosome amplification by targeting at the ROCK1/14-3-3σ complex in human colon cancer HCT116 cells.

Authors:  Yu Cheng Lu; Pu Wang; Jie Wang; Ronald Ma; Shao Chin Lee
Journal:  J Cell Physiol       Date:  2018-11-27       Impact factor: 6.384

6.  Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.

Authors:  Fariba Mohammadi; Hossein Javid; Amir Reza Afshari; Baratali Mashkani; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2020-05-20       Impact factor: 2.316

7.  WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells.

Authors:  Hai-Lan Yu; Xu-Dong Ma; Jin-Fei Tong; Jian-Qiong Li; Xiao-Jing Guan; Jian-Hua Yang
Journal:  Onco Targets Ther       Date:  2019-08-06       Impact factor: 4.147

Review 8.  Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Linh D Do; Brianne G Hritz
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

9.  Comprehensive analysis of mRNA-level and miRNA-level subpathway activities for identifying robust ovarian cancer prognostic signatures.

Authors:  Songyu Tian; Wanqi Mi; Mingyue Zhang; Linan Xing; Chunlong Zhang
Journal:  J Cell Mol Med       Date:  2020-01-19       Impact factor: 5.310

10.  Leptin Is Associated with Poor Clinical Outcomes and Promotes Clear Cell Renal Cell Carcinoma Progression.

Authors:  Wen-Lang Fan; Yuan-Ming Yeh; Tsung-Ta Liu; Wei-Ming Lin; Tse-Yen Yang; Chao-Wei Lee; Tsung-Chieh Lin
Journal:  Biomolecules       Date:  2021-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.